Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2026-02-28 @ 11:15 AM
Study NCT ID:
NCT06054906
Status:
RECRUITING
Last Update Posted:
2024-12-30
First Post:
2023-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
Sponsor:
Huashan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-12
First Submit QC Date:
None
Study First Post Date:
2023-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-28
Last Update Post Date:
2024-12-30
Last Update Post Date Type:
ACTUAL